Biolase Technology, Inc. (NASDAQ: BIOL) has closed its previously announced agreement to sell 2,688,172 shares of common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE